Thesis defense Gerjon Ikink

28-09-2018

Tomorrow Gerjon Ikink will defend his thesis on the discovery of genes involved in breast cancer. Genes called ERAS and IRS4 turn out to be responsible for breast tumor (HER2+) growth and resistance to commonly used targeted therapies. New drugs aiming to block this resistance mechanism are already being developed. Good luck tomorrow Gerjon!

This site uses cookies

This website uses cookies to ensure you get the best experience on our website.